Comparative analysis of the regeneratory potential of blood derivatives on a cell model of corneal epithelium damage



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of the restoration of the epithelial layer after various modifications of keratoplasty is of great fundamental interest. In this regard, new methods of induction of regeneration are being developed; one of the promising approaches in this area is the use of autologous blood derivatives with a high regenerative potential. Objective: to compare the effect of 3 blood derivatives serum, platelet-rich plasma and plasma rich growth factors on the culture of corneal epithelial cells. The study was carried out on cells of the epithelium of the human cornea of passage 3. To confirm corneal affiliation, cells were typed for characteristic cytokeratins. The dynamics of migration was assessed in the test for wound healing of the monolayer. Proliferation was assessed by the results of the formazan test. Plasma rich growth factors had the greatest stimulating effect on cell proliferation. There were no significant differences between groups in the rate of wound healing of the monolayer. It was found that, in comparison with the control, all stimulants shift the morphological phenotype of cells to a more mature side. As a result of the study, it was shown that all 3 types of tested blood derivatives are promoters of corneal re-epithelialization. The use of drugs obtained from blood can positively influence the processes of epithelialization in persistent epithelial corneal defects, which requires further study.

Full Text

Restricted Access

About the authors

A. M Subbot

Research Institute of Eye Diseases

S. V Trufanov

Research Institute of Eye Diseases

N. P Shakhbazyan

Research Institute of Eye Diseases

Email: nare_shakhbazyan@mail.ru

References

  1. Shimazaki J., Saito H., Yang H.Y. et al. Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea 1995; 14(6): 623-7.
  2. Mc Culley J.P., Horowitz B., Husseini Z.M. et al. Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group. Transactions of the American Ophthalmological Society 1993; 91: 367-90.
  3. Erdem E., Yagmur M., Harbiyeli I. et al. Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects. International journal of ophthalmology 2014; 7(5): 807-10.
  4. Fu Y., Liu J., Tseng S.C. Ocular surface deficits contributing to persistent epithelial defect after penetrating keratoplasty. Cornea 2012; 31(7): 723-9.
  5. Vaidyanathan U., Hopping G.C., Liu H.Y. et al. Persistent Corneal Epithelial Defects: A Review Article. Med. Hypothesis Discov. Innov. Ophthalmol. 2019; 8(3): 163-76.
  6. Ljubimov A.V., Saghizadeh M. Progress in corneal wound healing. Prog. Retin. Eye Res. 2015; 49: 17-45.
  7. Stramer B.M., Zieske J.D., Jung J.C. et al. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: Implications for surgical outcomes. Investig. Ophthalmol. Vis. Sci. 2003; 44: 4237-46.
  8. Khodadoust A.A., Silverstein A.M., Kenyon D.R. et al. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am.J. Ophthalmol. 1968; 65(3): 339-48.
  9. Torricelli A.A.M., Singh V., Agrawal V. et al. Transmission electron microscopy analysis of epithelial basement membrane repair in rabbit corneas with haze. Invest. Ophth. Vis. Sci. 2013; 54: 4026-33.
  10. Torricelli A.A.M., Singh V., Santhiago M.R. et al. The corneal epithelial basement membrane: Structure, function and disease. Invest. Ophth. Vis. Sci. 2013; 54: 6390-400.
  11. Singh V., Jaini R., Torricelli A.A. et al. TGFp and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo. Exp. Eye Res. 2014; 121: 35-40.
  12. Wilson S.E., He Y.G., Weng J. et al. Epithelial injury induces kerato-cyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp. Eye Res. 1996; 62(4): 325-7.
  13. Wilson S.E., Medeiros C.S., Santhiago M.R. et al. Pathophysiology of corneal scarring in persistent epithelial defects after PRK and other corneal injuries. J. Refract. Surg. 2018; 34(1): 59-64.
  14. Li D.Q., Lokeshwar B.L., Solomon A. et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp. Eye Res. 2001; 73(4): 449-59.
  15. Sivak J.M., Fini M.E. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog. Retin. Eye Res. 2002; 21(1): 1-14.
  16. Wilson S.E., Mohan R.R., Ambrosio R.Jr. et al. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog. Retin. Eye Res. 2001; 20(5): 625-37.
  17. Girard M.T., Matsubara M., Fini M.E. et al. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest. Ophthalmol. Vis. Sci. 1991; 32(9): 2441-54.
  18. Etulain J. Platelets in wound healing and regenerative medicine. Platelets 2018; 29(6): 556-68.
  19. Lopez-Plandolit S., Morales M.C., Freire V. et al. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 2010; 29(8): 843-8.
  20. Abu-Ameerh M.A., Jafar H.D., Hasan M.H. et al. Platelet lysate promotes re-epithelialization of persistent epithelial defects a pilot study. International ophthalmology 2018; 39(10): 1-8.
  21. Tsubota K., Goto E., Shimmura S. et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-9.
  22. Liu L., Hartwig D., Harloff S. et al. An optimized protocol for the production of autologous serum eye drops. Graefe’s Arch. Clin. Exp. Ophthalmol. 2005; 243(7): 706-14.
  23. Dhurat R., Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective. J. Cutan. Aesthet. Surg. 2014; 7(4): 189-97.
  24. Freire V., Andollo N., Etxebarria J. et al. In vitro effects of three blood derivatives on human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2012; 53(9): 5571-8.
  25. Giusti I., D’Ascenzo S., Macchiarelli G. et al. In vitro evidence supporting applications of platelet derivatives in regenerative medicine. Blood Transfus. 2020; 18(2): 117-29.
  26. Рогульская Е.Ю., Ревенко Е.Б., Петренко Ю.А. и др. Пролифе-ративно-дифференцировочный потенциал мультипотентных мезенхимальных стромальных клеток жировой ткани при культивировании в присутствии тромбоцитарного лизата. Гены & Клетки 2014; 9(2): 63-7.
  27. Сергеева Н.С., Шанский Я.Д., Свиридова И.К. и др. Биологические эффекты тромбоцитарного лизата при добавлении в среду культивирования клеток человека. Гены & Клетки 2014; 9(1): 77-85.
  28. Harkin D.G., Barnard Z., Gillies P. et al. Analysis of p63 and cytokeratin expression in a cultivated limbal autograft used in the treatment of limbal stem cell deficiency. Br.J. Ophthalmol. 2004; 88(9): 1154-8.
  29. Kim K.M., Shin Y.T., Kim H.K. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Japanese journal of ophthalmology 2012; 56(6): 544-50.
  30. Lopez-Plandolit S., Morales M.C., Freire V. et al. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 2010; 29(8): 843-8.
  31. Abu-Ameerh M.A., Jafar H.D., Hasan M.H. et al. Platelet lysate promotes re-epithelialization of persistent epithelial defects a pilot study. International ophthalmology 2019; 39(7): 1483-90.
  32. Huang C.J., Sun Y.C., Christopher K. et al. Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. PloS One 2017; 12(2): 1-16.
  33. Боровкова Н.В., Филатова И.А., Ченцова Е.В. и др. Эффективность применения лизата богатой тромбоцитами плазмы (БоТП) у пациентов с эрозией роговицы или посттравматическим рубцеванием тканей век. Российский офтальмологический журнал 2020; 13(3): 8-14.
  34. Лошкарева А.О., Майчук Д.Ю. Применение богатой тромбоцитами плазмы у пациентов с хроническими эрозиями роговицы. Современные технологии в офтальмологии 2016; 4: 131-2.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies